Enveric Biosciences Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Direxion Daily Semiconductor Bear 3X Shares trades at $50.67. Which is the better fit depends on your goals.
| ENVB | SOXS | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $1.61K |
52-Week Low | $1.28 | $32.50 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
SOXS, the Direxion Daily Semiconductor Bear 3X Shares ETF, surged 19.91% to $50.96 as semiconductor stocks faced pressure from competitive threats. The ETF shows a bullish technical signal with strong moving average support but overbought RSI readings. Recent corporate actions include a 1:10 stock split scheduled for July 2026 and a $0.04 dividend payment in June 2026. The fund provides 3x leveraged inverse exposure to the semiconductor sector, benefiting from recent market volatility.
SOXS offers tactical exposure to semiconductor sector declines but carries significant risks due to its leveraged structure and the strong fundamental support for AI-driven chip demand. The ETF's performance remains highly dependent on semiconductor market volatility rather than traditional company fundamentals. Investors should be cautious of decay effects and the challenging environment for bearish semiconductor positioning given current industry momentum.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →